Literature DB >> 18635960

TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development.

Muh-Hwa Yang1, Kou-Juey Wu.   

Abstract

Hypoxia is a microenvironmental factor which plays a critical role in development and tumor progression. The hypoxic response is mainly mediated by hypoxia inducible factor-1 (HIF-1) composed of HIF-1alpha and HIF-1beta, which becomes active under low oxygen condition. HIF-1 activates the transcription of hypoxia inducible genes which regulate diverse cellular functions including metabolism, angiogenesis and invasion. In cancer metastasis, HIF-1-regulated genes promote angiogenesis, invasion and epithelial-mesenchymal transition (EMT), a critical step of metastasis. TWIST is a master regulator of gastrulation and mesoderm specification and is recently implicated to be essential to mediate cancer metastasis. We recently showed that HIF-1 promotes EMT through direct regulation of TWIST expression. TWIST is critical for hypoxia mediated EMT and metastasis. TWIST plays a non-redundant role in relation to other EMT regulators (e.g., Snail) under hypoxia. Co-expression of HIF-1alpha, TWIST and Snail could be used as a prognostic marker in cancer patients. These findings suggest that hypoxia and/or HIF-1 orchestrates EMT and metastasis through the coordinated regulation of different EMT regulators. Our results provide the important link between hypoxia and developmental processes regulated by TWIST. The implications of the roles of hypoxia and TWIST in early embryonic development are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635960     DOI: 10.4161/cc.7.14.6324

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  134 in total

1.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

2.  Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

Authors:  Jen-Liang Su; Poshen B Chen; Ya-Huey Chen; Shang-Chih Chen; Yi-Wen Chang; Yi-Hua Jan; Xiaoyun Cheng; Michael Hsiao; Mien-Chie Hung
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation.

Authors:  Chih-Hsien Wu; Sheau-Chung Tang; Po-Hui Wang; Huei Lee; Jiunn-Liang Ko
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

4.  Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma.

Authors:  Chi-Chen Fan; Tao-Yeuan Wang; Yen-An Cheng; Shih Sheng Jiang; Chien-Wen Cheng; Alan Yueh-Luen Lee; Ting-Yu Kao
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-30       Impact factor: 4.553

5.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

Review 6.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

7.  Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.

Authors:  Chi-Hung Huang; Wen-Hao Yang; Shyue-Yih Chang; Shyh-Kuan Tai; Cheng-Hwei Tzeng; Jung-Yie Kao; Kou-Juey Wu; Muh-Hwa Yang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

9.  Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.

Authors:  Nannan Lv; Zhongyan Shan; Yun Gao; Haixia Guan; Chenling Fan; Hong Wang; Weiping Teng
Journal:  Endocrine       Date:  2015-08-20       Impact factor: 3.633

10.  Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury.

Authors:  Caixia Li; Min Xia; Justine M Abais; Xiaocheng Liu; Ningjun Li; Krishna M Boini; Pin-Lan Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.